The DOI matches its Crossref record; 26 of the 27 references it cites were found in a registry or an index.
Reductive carboxylation supports growth in tumour cells with defective mitochondria
Open accessAbstract
Mitochondrial metabolism provides precursors to build macromolecules in growing cancer cells. In normally functioning tumour cell mitochondria, oxidative metabolism of glucose- and glutamine-derived carbon produces citrate and acetyl-coenzyme A for lipid synthesis, which is required for tumorigenesis. Yet some tumours harbour mutations in the citric acid cycle (CAC) or electron transport chain (ETC) that disable normal oxidative mitochondrial function, and it is unknown how cells from such tumours generate precursors for macromolecular synthesis. Here we show that tumour cells with defective mitochondria use glutamine-dependent reductive carboxylation rather than oxidative metabolism as the major pathway of citrate formation. This pathway uses mitochondrial and cytosolic isoforms of NADP(+)/NADPH-dependent isocitrate dehydrogenase, and subsequent metabolism of glutamine-derived citrate provides both the acetyl-coenzyme A for lipid synthesis and the four-carbon intermediates needed to produce the remaining CAC metabolites and related macromolecular precursors. This reductive, glutamine-dependent pathway is the dominant mode of metabolism in rapidly growing malignant cells containing mutations in complex I or complex III of the ETC, in patient-derived renal carcinoma cells with mutations in fumarate hydratase, and in cells with normal mitochondria subjected to acute pharmacological ETC inhibition. Our findings reveal the novel induction of a versatile glutamine-dependent pathway that reverses many of the reactions of the canonical CAC, supports tumour cell growth, and explains how cells generate pools of CAC intermediates in the face of impaired mitochondrial metabolism.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Although oxidation of glutamine-derived α-KG in the TCA cycle serves as a minor source of lipogenic acetyl-CoA under normal growth conditions, α-KG can be converted to citrate through reductive carboxylation under conditions of stress such as hypoxia or mitochondrial dysfunction (70–72).”
From Fueling Immunity: Insights into Metabolism and Lymphocyte Function (2013) · cites this paper as [70]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“In the context of constitutive HIF-2α stabilization75 or a defective mitochondrial electron transport chain76, glutamine-derived α-KG is reductively carboxylated through the consumption of NADPH by IDH2 to generate citrate.”
From Glutamine reliance in cell metabolism (2020) · cites this paper as [76]
In the citing paper
“Similarly, checkpoint kinase 1 (CHK1) inhibitors625–627 and glutaminase (GLS) inhibitors628–634 are also considered potential candidates for treating Myc-overexpressing cancers.”
From Recent advances in targeting the “undruggable” proteins: from drug discovery to clinical trials (2023) · cites this paper as [630]
In the citing paper
“Previous reports showed that reductive carboxylation is a critical pathway to support the growth of tumor cells under hypoxia (Metallo, 2012; Mullen, 2012).”
From Tumor microenvironment derived exosomes pleiotropically modulate cancer cell metabolism (2016) · cites this paper as Mullen, 2012
In the citing paper
“The upregulation of the reductive carboxylation pathway enhances cancer cells proliferation (Metallo, 2012; Mullen, 2012; Wise et al., 2011).”
From Tumor microenvironment derived exosomes pleiotropically modulate cancer cell metabolism (2016) · cites this paper as Mullen, 2012
In the citing paper
“For example, under conditions of hypoxia or impaired mitochondrial respiration, certain reactions of the TCA cycle reverse to support glutamine-dependent reductive carboxylation (92, 122, 123).”
From Regulation and function of the mammalian tricarboxylic acid cycle (2023) · cites this paper as [123]
In the citing paper
“Citrate is generated by citrate synthase (CS) or through the reduction of α-ketoglutarate by isocitrate dehydrogenase (IDH).79–81”
From The multifaceted contributions of mitochondria to cellular metabolism (2018) · cites this paper as [80]
In the citing paper
“Glutamine can contribute carbon to fatty acid synthesis via reductive carboxylation or oxidative glutaminolysis.”
From Regulation of Substrate Utilization by the Mitochondrial Pyruvate Carrier (2014) · cites this paper as Mullen et al., 2012
In the citing paper
“The former pathway is highly active in cells proliferating under hypoxia or those with a compromised respiratory chain (Metallo et al., 2012; Mullen et al., 2012; Scott et al., 2011; Wise et al., 2011), while the latter pathway has been observed in B cell lymphoma (Le et al., 2012).”
From Regulation of Substrate Utilization by the Mitochondrial Pyruvate Carrier (2014) · cites this paper as Mullen et al., 2012
In the citing paper
“In place of oxidative metabolism of both glucose and glutamine, these cancers preferentially perform reductive and carboxylating biosynthetic reactions from glutamine carbon (Le et al., 2012; Metallo et al., 2012; Mullen et al., 2012; Wise et al., 2011).”
From Metabolic Reprogramming: A Cancer Hallmark Even Warburg Did Not Anticipate (2012) · cites this paper as Mullen et al., 2012
In the citing paper
“Recently three independent reports implicated IDH-dependent reductive carboxylation as playing a particularly important role in proliferating cells that exhibit decreased flux of glucose-derived pyruvate into the mitochondria. This occurs in hypoxic cells or in cells harboring defects in mitochondrial oxidative phosphorylation (Metallo et al., 2012; Mullen et al., 2012; Wise et al., 2011).”
From Metabolic Reprogramming: A Cancer Hallmark Even Warburg Did Not Anticipate (2012) · cites this paper as Mullen et al., 2012
In the citing paper
“tumor cells with mutations in the TCA cycle or ETC (Mullen et al., 2011), or with hypoxia-induced suppression of oxidative metabolism (Metallo et al., 2011; Scott et al., 2011; Wise et al., 2011) use reductive carboxylation of α-KG to produce citrate and other precursors during growth.”
From Cellular Metabolism and Disease: What Do Metabolic Outliers Teach Us? (2012) · cites this paper as Mullen et al., 2011
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Branched tricarboxylic acid metabolism in Plasmodium falciparum
Olszewski, K. L., Mather, M. W., Morrisey, J. M., Garcia, B. A., Vaidya, A. B., Rabinowitz, J. D., & Llinás, M. (2010) · Nature · doi:10.1038/nature09301 · Cited by 124
RetractedUnderstanding the Warburg Effect: The Metabolic Requirements of Cell Proliferation
Vander Heiden, M. G., Cantley, L. C., & Thompson, C. B. (2009) · Science · doi:10.1126/science.1160809 · Cited by 16,197
DeBerardinis, R. J., Mancuso, A., Daikhin, E., Nissim, I., Yudkoff, M., Wehrli, S., & Thompson, C. B. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0709747104 · Cited by 2,622
Self-citationGao, P., Tchernyshyov, I., Chang, T.-C., Lee, Y.-S., Kita, K., Ochi, T., Zeller, K. I., De Marzo, A. M., Van Eyk, J. E., Mendell, J. T., et al. (2009) · Nature · doi:10.1038/nature07823 · Cited by 2,124
Ward, P. S., Patel, J., Wise, D. R., Abdel-Wahab, O., Bennett, B. D., Coller, H. A., Cross, J. R., Fantin, V. R., Hedvat, C. V., Perl, A. E., et al. (2010) · Cancer Cell · doi:10.1016/j.ccr.2010.01.020 · Cited by 2,020
Mitochondrial metabolism and ROS generation are essential for Kras-mediated tumorigenicity
Weinberg, F., Hamanaka, R., Wheaton, W. W., Weinberg, S., Joseph, J., Lopez, M., Kalyanaraman, B., Mutlu, G. M., Budinger, G. R. S., & Chandel, N. S. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1003428107 · Cited by 1,742
Self-citationMutations in SDHD , a Mitochondrial Complex II Gene, in Hereditary Paraganglioma
Baysal, B. E., Ferrell, R. E., Willett-Brozick, J. E., Lawrence, E. C., Myssiorek, D., Bosch, A., Mey, A. V. D., Taschner, P. E. M., Rubinstein, W. S., Myers, E. N., et al. (2000) · Science · doi:10.1126/science.287.5454.848 · Cited by 1,638
The Multiple Leiomyoma Consortium (2002) · Nature Genetics · doi:10.1038/ng849 · Cited by 1,635
El-Mir, M.-Y., Nogueira, V., Fontaine, E., Avéret, N., Rigoulet, M., & Leverve, X. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.1.223 · Cited by 1,399
Q's next: the diverse functions of glutamine in metabolism, cell biology and cancer
DeBerardinis, R. J., & Cheng, T. (2010) · Oncogene · doi:10.1038/onc.2009.358 · Cited by 1,365
Self-citation
Cited by
Sorted by citations
Items 601–700 of 1,000
AMPK: opposing the metabolic changes in both tumour cells and inflammatory cells?
Dandapani, M., & Hardie, D. G. (2013) · Biochemical Society Transactions · doi:10.1042/bst20120351 · Cited by 47
Carbon Source and Myc Expression Influence the Antiproliferative Actions of Metformin
Javeshghani, S., Zakikhani, M., Austin, S., Bazile, M., Blouin, M., Topisirović, I., St‐Pierre, J., & Pollak, M. (2012) · Cancer Research · doi:10.1158/0008-5472.can-12-2907 · Cited by 49
José, C., Melser, S., Bénard, G., & Rossignol, R. (2012) · Antioxidants and Redox Signaling · doi:10.1089/ars.2011.4357 · Cited by 51
Glucose-derived acetate and ACSS2 as key players in cisplatin resistance in bladder cancer
He, W., Lee, S.-J., Zhu, W., Lee, O.-J., Yun, S. J., Kim, J., & Park, S. (2018) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2018.06.005 · Cited by 46
Regulation of the redox metabolome and thiol proteome by hydrogen sulfide
Kumar, R., & Banerjee, R. V. (2021) · Critical Reviews in Biochemistry and Molecular Biology · doi:10.1080/10409238.2021.1893641 · Cited by 48
Rodrigues, M. F., Carvalho, É., Pezzuto, P., Rumjanek, F. D., & Amoêdo, N. D. (2014) · Journal of Cellular Biochemistry · doi:10.1002/jcb.25036 · Cited by 48
Kiweler, N., Delbrouck, C., Pozdeev, V. I., Neises, L., Soriano‐Baguet, L., Eiden, K., Xian, F., Benzarti, M., Haase, L., Koncina, E., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-30363-y · Cited by 46
Acetate metabolism in cancer cells
Hosios, A. M., & Heiden, M. G. V. (2014) · Cancer & Metabolism · doi:10.1186/s40170-014-0027-y · Cited by 45
Ying, M., Guo, C., & Hu, X. (2019) · Journal of Biological Chemistry · doi:10.1074/jbc.ra119.007841 · Cited by 45
Vallée, A., Vallée, J.-N., & Lecarpentier, Y. (2019) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2019.05.024 · Cited by 46
Hypoxia, hypoxia-inducible gene 2 (HIG2)/HILPDA, and intracellular lipolysis in cancer
Povero, D., Johnson, S. M., & Liu, J. (2020) · Cancer Letters · doi:10.1016/j.canlet.2020.06.013 · Cited by 46
Serine Biosynthesis Is a Metabolic Vulnerability in IDH2-Driven Breast Cancer Progression
Barnabas, G. D., Lee, J. S., Shami, T., Harel, M., Beck, L., Selitrennik, M., Jerby‐Arnon, L., Erez, N., Ruppin, E., & Geiger, T. (2021) · Cancer Research · doi:10.1158/0008-5472.can-19-3020 · Cited by 45
A Metabolic Paradigm for Hydrogen Sulfide Signaling via Electron Transport Chain Plasticity
Hanna, D. A., Kumar, R., & Banerjee, R. V. (2022) · Antioxidants and Redox Signaling · doi:10.1089/ars.2022.0067 · Cited by 45
Connecting Metabolic Rewiring With Phenotype Switching in Melanoma
Falletta, P., Goding, C. R., & Vivas, Y. (2022) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2022.930250 · Cited by 46
Badur, M. G., & Metallo, C. M. (2017) · Metabolic Engineering · doi:10.1016/j.ymben.2017.11.013 · Cited by 44
Shi, Y. X., Dou, Y., Zhang, J., Qi, J., Xin, Z., Zhang, M., Xiao, Y. P., & Ci, W. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.737498 · Cited by 45
Helenius, I. T., Madala, H. R., & Yeh, J.-R. J. (2021) · Biomolecules · doi:10.3390/biom11111666 · Cited by 43
Mitochondrial Redox Metabolism: The Epicenter of Metabolism during Cancer Progression
Choudhury, F. K. (2021) · Antioxidants · doi:10.3390/antiox10111838 · Cited by 44
The Tumor Suppressor Kinase LKB1: Metabolic Nexus
Bourouh, M., & Marignani, P. A. (2022) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2022.881297 · Cited by 48
100 years of the Warburg effect: a historical perspective
Hardie, D. G. (2022) · Endocrine Related Cancer · doi:10.1530/erc-22-0173 · Cited by 43
IDH Mutations in Glioma: Molecular, Cellular, Diagnostic, and Clinical Implications
Choate, K. A., Pratt, E. P. S., Jennings, M. J., Winn, R. J., & Mann, P. B. (2024) · Biology · doi:10.3390/biology13110885 · Cited by 49
Verma, A., & Lindroth, A. M. (2025) · Experimental & Molecular Medicine · doi:10.1038/s12276-025-01537-7 · Cited by 47
Stress eating and tuning out: Cancer cells re-wire metabolism to counter stress
Stine, Z. E., & Dang, C. V. (2013) · Critical Reviews in Biochemistry and Molecular Biology · doi:10.3109/10409238.2013.844093 · Cited by 44
OXPHOS dysfunction regulates integrin- 1 modifications and enhances cell motility and migration
Nunes, J. B., Peixoto, J., Soares, P., Máximo, V., Carvalho, S., Pinho, S. S., Vieira, A. F., Paredes, J., Rego, A. C., Ferreira, I. L., et al. (2014) · Human Molecular Genetics · doi:10.1093/hmg/ddu612 · Cited by 45
Hwang, V. J., Kim, J., Rand, A. A., Yang, C., Sturdivant, S., Hammock, B. D., Bell, P. D., Guay‐Woodford, L. M., & Weiss, R. H. (2015) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00238.2015 · Cited by 43
Mitochondrial dysfunction and potential anticancer therapy
LLeonart, M. E., Grodzicki, R., Graifer, D. M., & Lyakhovich, A. (2017) · Medicinal Research Reviews · doi:10.1002/med.21459 · Cited by 43
Metabolic Signaling to Epigenetic Alterations in Cancer
Kim, J., & Yeom, Y. I. (2017) · Biomolecules & Therapeutics · doi:10.4062/biomolther.2017.185 · Cited by 45
The Fate of Glutamine in Human Metabolism. The Interplay with Glucose in Proliferating Cells
Mazat, J., & Ransac, S. (2019) · Metabolites · doi:10.3390/metabo9050081 · Cited by 44
Role of coenzymes in cancer metabolism
Thapa, M., & Dallmann, G. (2019) · Seminars in Cell and Developmental Biology · doi:10.1016/j.semcdb.2019.05.027 · Cited by 45
Kaira, K., Sunose, Y., Arakawa, K., Sunaga, N., Shimizu, K., Tominaga, H., Oriuchi, N., Nagamori, S., Kanai, Y., Oyama, T., et al. (2014) · Histopathology · doi:10.1111/his.12464 · Cited by 43
Linehan, W. M., & Rathmell, W. K. (2012) · Urologic Oncology Seminars and Original Investigations · doi:10.1016/j.urolonc.2012.08.021 · Cited by 43
Self-citationGorgoglione, R., Impedovo, V., Riley, C. L., Fratantonio, D., Tiziani, S., Palmieri, L., Dolce, V., & Fiermonte, G. (2022) · Cancers · doi:10.3390/cancers14010245 · Cited by 44
Itaconate controls its own synthesis via feedback-inhibition of reverse TCA cycle activity at IDH2
Heinz, A., Nonnenmacher, Y., Henne, A., Khalil, M., Bejkollari, K., Dostert, C., Hosseini, S., Goldmann, O., He, W., Palorini, R., et al. (2022) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2022.166530 · Cited by 42
Improving the description of metabolic networks: the TCA cycle as example
Stobbe, M. D., Houten, S. M., van Kampen, A. H. C., Wanders, R. J. A., & Moerland, P. D. (2012) · The FASEB Journal · doi:10.1096/fj.11-203091 · Cited by 42
Global metabolomic profiling of uterine leiomyomas
Heinonen, H.-R., Mehine, M. M., Mäkinen, N., Pasanen, A. M., Pitkänen, E., Karhu, A., Sarvilinna, N. S., Sjöberg, J., Heikinheimo, O., Bützow, R. C., et al. (2017) · British Journal of Cancer · doi:10.1038/bjc.2017.361 · Cited by 43
Linehan, W. M., Srinivasan, R., & Garcia, J. A. (2013) · Seminars in Oncology · doi:10.1053/j.seminoncol.2013.05.009 · Cited by 42
Self-citationBotman, D., Tigchelaar, W., & Noorden, C. J. F. V. (2014) · Journal of Histochemistry & Cytochemistry · doi:10.1369/0022155414551177 · Cited by 41
ETA: Robust software for determination of cell specific rates from extracellular time courses
Murphy, T. A., & Young, J. D. (2013) · Biotechnology and Bioengineering · doi:10.1002/bit.24836 · Cited by 41
PKM2 promotes reductive glutamine metabolism
Miao, L., Yuanyuan, W., Yuxia, R., Changsen, B., Li, Q., Yanfen, C., Guoguang, Y., & Binghui, L. (2018) · Cancer Biology and Medicine · doi:10.20892/j.issn.2095-3941.2018.0122 · Cited by 42
Nitric Oxide Modulates Metabolic Processes in the Tumor Immune Microenvironment
McGinity, C. L., Palmieri, E. M., Somasundaram, V., Bhattacharyya, D. D., Ridnour, L. A., Cheng, R. Y. S., Ryan, A. E., Glynn, S. A., Thomas, D. D., Miranda, K. M., et al. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22137068 · Cited by 44
Cancer anabolic metabolism inhibitors move into clinic
Garber, K. (2016) · Nature Biotechnology · doi:10.1038/nbt0816-794 · Cited by 41
Nutrient inputs and social metabolic control of T cell fate
Bacigalupa, Z. A., Landis, M. D., & Rathmell, J. C. (2023) · Cell Metabolism · doi:10.1016/j.cmet.2023.12.009 · Cited by 45
Kotarsky, H., Keller, M., Davoudi, M., Levéen, P., Karikoski, R., Enot, D. P., & Fellman, V. (2012) · PLoS ONE · doi:10.1371/journal.pone.0041156 · Cited by 42
Cancer metabolism as a central driving force of glioma pathogenesis
Masui, K., Cavenee, W. K., & Mischel, P. S. (2016) · Brain Tumor Pathology · doi:10.1007/s10014-016-0265-5 · Cited by 40
Metabolic Reprogramming of Cancer by Chemicals that Target Glutaminase Isoenzymes
Matés, J. M., Campos-Sandoval, J. A., Santos-Jiménez, J. D. L., Segura, J. A., Alonso, F. J., & Márquez, J. (2019) · Current Medicinal Chemistry · doi:10.2174/0929867326666190416165004 · Cited by 41
Liao, C., Li, M., Li, X., Li, N., Zhao, X., Wang, X., Song, Y., Quan, J., Cheng, C., Liu, J., et al. (2019) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2019.158540 · Cited by 40
Cytosolic ME1 integrated with mitochondrial IDH2 supports tumor growth and metastasis
Shao, C., Lu, W., Du, Y., Yan, W., Bao, Q., Tian, Y., Wang, G., Ye, H., & Hao, H. (2020) · Redox Biology · doi:10.1016/j.redox.2020.101685 · Cited by 41
Fluorescence microscopy imaging of mitochondrial metabolism in cancer cells
Gooz, M. B., & Maldonado, E. N. (2023) · Frontiers in Oncology · doi:10.3389/fonc.2023.1152553 · Cited by 44
Pathogenic mitochondrial DNA mutations inhibit melanoma metastasis
Shelton, S. D., House, S., Melo, L. M. N., Ramesh, V., Chen, Z., Wei, T., Wang, X., Llamas, C. B., Venigalla, S. S. K., Menezes, C. J., et al. (2024) · Science Advances · doi:10.1126/sciadv.adk8801 · Cited by 39
Self-citationThe role of mammalian sirtuins in cancer metabolism
Sebastián, C., & Mostoslavsky, R. (2015) · Seminars in Cell and Developmental Biology · doi:10.1016/j.semcdb.2015.07.008 · Cited by 39
Darpolor, M. M., Basu, S. S., Worth, A., NELSON, D. S., Katzenberg, R. H., Glickson, J. D., Kaplan, D. E., & Blair, I. A. (2014) · NMR in Biomedicine · doi:10.1002/nbm.3072 · Cited by 39
IDH1, lipid metabolism and cancer: Shedding new light on old ideas
Bogdanovic, E. (2015) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2015.04.014 · Cited by 39
Reductive carboxylation and 2-hydroxyglutarate formation by wild-type IDH2 in breast carcinoma cells
Smolková, K., Dvořák, A., Zelenka, J., Vı́tek, L., & Ježek, P. (2015) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2015.05.012 · Cited by 39
Joly, J. H., Lowry, W. E., & Graham, N. A. (2020) · Bioinformatics · doi:10.1093/bioinformatics/btaa658 · Cited by 41
Amino acid metabolism in tumor: New shine in the fog?
Qiu, H., Shao, N., Liu, J., Zhao, J.-J., Chen, C., Li, Q., He, Z., Zhao, X., & Xu, L. (2023) · Clinical Nutrition · doi:10.1016/j.clnu.2023.06.011 · Cited by 38
The Warburg effect: The hacked mitochondrial-nuclear communication in cancer
Jiang, H., & Ye, J. (2025) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2025.03.006 · Cited by 40
Féron, O. (2019) · Annals of Translational Medicine · doi:10.21037/atm.2019.11.140 · Cited by 39
Wei, P., Bott, A. J., Cluntun, A. A., Morgan, J. T., Cunningham, C. N., Schell, J. C., Ouyang, Y., Ficarro, S. B., Marto, J. A., Danial, N. N., et al. (2022) · Science Advances · doi:10.1126/sciadv.abq0117 · Cited by 39
Self-citationCancer-Associated Fibroblast Diversity Shapes Tumor Metabolism in Pancreatic Cancer
Peiffer, R., Boumahd, Y., Gullo, C., Crake, R., Letellier, E., Bellahcène, A., & Peulen, O. (2022) · Cancers · doi:10.3390/cancers15010061 · Cited by 38
The Involvement of PPARs in the Peculiar Energetic Metabolism of Tumor Cells
Antonosante, A., d’Angelo, M., Castelli, V., Catanesi, M., Iannotta, D., Giordano, A., Ippoliti, R., Benedetti, E., & Cimini, A. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19071907 · Cited by 37
Different Tumor Microenvironments Lead to Different Metabolic Phenotypes
Antonio, M. J., & Le, A. (2018) · Advances in experimental medicine and biology · doi:10.1007/978-3-319-77736-8_9 · Cited by 37
Urra, F. A., Fuentes-Retamal, S., Palominos, C., Rodríguez-Lucart, Y. A., López-Torres, C., & Araya‐Maturana, R. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.751301 · Cited by 38
Clinical development of IDH1 inhibitors for cancer therapy
Zarei, M., Hue, J. J., Hajihassani, O., Graor, H. J., Katayama, E., Loftus, A. W., Bajor, D. L., Rothermel, L. D., Gohar, A. V., & Winter, J. M. (2021) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2021.102334 · Cited by 39
Wynn, M. L., Yates, J. A., Evans, C. R., Wassenhove, L. D. V., Wu, Z.-F., Bridges, S., Bao, L., Fournier, C. L., Ashrafzadeh, S., Merrins, M. J., et al. (2016) · Journal of Biological Chemistry · doi:10.1074/jbc.m115.703959 · Cited by 37
Changes in Metabolites Present in Lung-Lining Fluid Following Exposure of Humans to Ozone
Cheng, W., Duncan, K., Ghio, A. J., Ward-Caviness, C. K., Karoly, E. D., Díaz-Sánchez, D., Conolly, R. B., & Devlin, R. B. (2018) · Toxicological Sciences · doi:10.1093/toxsci/kfy043 · Cited by 37
Regulation of tumor metabolism by post translational modifications on metabolic enzymes
Dessai, A. S., Kalhotra, P., Novickis, A. T., & Dasgupta, S. (2022) · Cancer Gene Therapy · doi:10.1038/s41417-022-00521-x · Cited by 38
Joshi, S., Liu, M., & Turner, N. A. (2015) · BioMed Research International · doi:10.1155/2015/390863 · Cited by 36
He, S.-T., Lee, D.-Y., Tung, C.-Y., Li, C.-Y., & Wang, H. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.02102 · Cited by 37
Bouthelier, A., & Aragonés, J. (2020) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2020.118733 · Cited by 37
MacPherson, S., Keyes, S., Kilgour, M. K., Smazynski, J., Chan, V., Sudderth, J., Turcotte, T., Devlieger, A., Yu, J. Z., Huggler, K. S., et al. (2022) · Molecular Therapy — Methods & Clinical Development · doi:10.1016/j.omtm.2022.02.004 · Cited by 42
Self-citationFu, X., Huang, X., Li, P., Chen, W., & Xia, M. (2014) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2014.03.010 · Cited by 36
Fernández-García, E., Paudel, U., Noji, M., Bowman, C. E., Pitarresi, J. R., Rustgi, A. K., Wellen, K. E., Arany, Z. P., Weissenrieder, J., & Foskett, J. K. (2023) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2023.1082213 · Cited by 35
Wild-type IDH2 is a therapeutic target for triple-negative breast cancer
Li, J., Yu., T. S., Zeng, P., Tian, J., Liu, P., Qiao, S., Wen, S., Hu, Y., Liu, Q., Lu, W., et al. (2024) · Nature Communications · doi:10.1038/s41467-024-47536-6 · Cited by 38
MicroRNA regulation of cancer metabolism: role in tumour suppression
Tomasetti, M., Santarelli, L., Neužil, J., & Dong, L. (2014) · Mitochondrion · doi:10.1016/j.mito.2014.06.004 · Cited by 36
Discoveries, therapies and opportunities
Linehan, W. M., & Ricketts, C. J. (2014) · Nature Reviews Urology · doi:10.1038/nrurol.2014.262 · Cited by 35
Self-citationLin28 enhances de novo fatty acid synthesis to promote cancer progression via SREBP‐1
Zhang, Y., Li, C., Hu, C., Wu, Q., Cai, Y., Xing, S., Lu, H. J., Wang, L., Huang, D., Sun, L., et al. (2019) · EMBO Reports · doi:10.15252/embr.201948115 · Cited by 35
Take Advantage of Glutamine Anaplerosis, the Kernel of the Metabolic Rewiring in Malignant Gliomas
Martins, F., Gonçalves, L. G., Pojo, M., & Serpa, J. (2020) · Biomolecules · doi:10.3390/biom10101370 · Cited by 35
Nonnenmacher, Y., Palorini, R., d’Hérouël, A. F., Krämer, L., Neumann‐Schaal, M., Chiaradonna, F., Skupin, A., Wegner, A., & Hiller, K. (2016) · Metabolic Engineering · doi:10.1016/j.ymben.2016.12.005 · Cited by 35
Mitochondria and CancerPreprint
Kenny, T. C., & Birsoy, K. (2024) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a041534 · Cited by 40
Lin, P., Lu, Y., Zheng, J., Lin, Y., Zhao, X., & Cui, L. (2024) · Journal of Nanobiotechnology · doi:10.1186/s12951-024-02585-3 · Cited by 35
Identification of Fumarate Hydratase Inhibitors with Nutrient-Dependent Cytotoxicity
Takeuchi, T., Schumacker, P. T., & Kozmin, S. A. (2014) · Journal of the American Chemical Society · doi:10.1021/ja5101257 · Cited by 34
Active mitochondrial respiration in cancer: a target for the drug
Bedi, M., Ray, M., & Ghosh, A. (2021) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-021-04281-4 · Cited by 34
Metabolic therapy and bioenergetic analysis: The missing piece of the puzzle
Duraj, T., Carrión-Navarro, J., Seyfried, T. N., Garcia‐Romero, N., & Ayuso‐Sacido, Á. (2021) · Molecular Metabolism · doi:10.1016/j.molmet.2021.101389 · Cited by 36
Shi, Y., Wang, S., Yang, R., Wang, Z., Zhang, W., Liu, H., & Huang, Y. (2022) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2022/1084006 · Cited by 36
Distinct mTORC1 pathways for transcription and cleavage of SREBP-1c
Quinn, W. J., & Birnbaum, M. J. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1214113109 · Cited by 34
Cancer cell metabolism regulates extracellular matrix degradation by invadopodia
van Horssen, R., Buccione, R., Willemse, M. P., Köker, Ş. C., Wieringa, B., & Attanasio, F. (2013) · European Journal of Cell Biology · doi:10.1016/j.ejcb.2012.11.003 · Cited by 34
Hohnholt, M. C., Blumrich, E., Waagepetersen, H. S., & Dringen, R. (2017) · Journal of Neuroscience Research · doi:10.1002/jnr.24050 · Cited by 34
A systems approach reveals distinct metabolic strategies among the NCI-60 cancer cell lines
Aurich, M. K., Fleming, R. M. T., & Thiele, I. (2017) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1005698 · Cited by 33
Zhang, Q., Guo, X., Xie, C., Cao, Z., Wang, X., Liu, L., & Yang, P. (2021) · Pharmacological Research · doi:10.1016/j.phrs.2021.105884 · Cited by 33
A “Weird” Mitochondrial Fatty Acid Oxidation as a Metabolic “Secret” of Cancer
Zhelev, Z., Aoki, I., Lazarova, D., Vlaykova, T. I., Higashi, T., & Bakalova, R. (2022) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2022/2339584 · Cited by 34
Cellular metabolism in pancreatic cancer as a tool for prognosis and treatment (Review)
Zuzčák, M., & Trnka, J. (2022) · International Journal of Oncology · doi:10.3892/ijo.2022.5383 · Cited by 33
Stable Isotope Tracer Analysis in Isolated Mitochondria from Mammalian Systems
Gravel, S., Andrzejewski, S., Avizonis, D. Z., & St‐Pierre, J. (2014) · Metabolites · doi:10.3390/metabo4020166 · Cited by 37
Altered Mitochondrial Signalling and Metabolism in Cancer
Chattopadhyay, E., & Roy, B. (2017) · Frontiers in Oncology · doi:10.3389/fonc.2017.00043 · Cited by 36
Metabolic regulation in HPV associated head and neck squamous cell carcinoma
Chandel, V., Raj, S., Kumar, P., Gupta, S., Dhasmana, A., Kesari, K. K., Ruokolainen, J., Mehra, P., Das, B. C., Kamal, M. A., et al. (2020) · Life Sciences · doi:10.1016/j.lfs.2020.118236 · Cited by 33
IDH1 Inhibition Potentiates Chemotherapy Efficacy in Pancreatic Cancer
Zarei, M., Hajihassani, O., Hue, J. J., Loftus, A. W., Graor, H. J., Nakazzi, F., Naji, P., Boutros, C. S., Uppin, V., Gohar, A. V., et al. (2024) · Cancer Research · doi:10.1158/0008-5472.can-23-1895 · Cited by 34
Metabolic modulation of cancer: a new frontier with great translational potential
Kinnaird, A. S., & Michelakis, E. D. (2015) · Journal of Molecular Medicine · doi:10.1007/s00109-014-1250-2 · Cited by 32
Metabolic Regulation in Mitochondria and Drug Resistance
Pan, Y., Cao, M., Liu, J., Yang, Q. K., Miao, X., Go, V. L. W., Lee, P. W. N., & Xiao, G. G. (2017) · Advances in experimental medicine and biology · doi:10.1007/978-981-10-6674-0_11 · Cited by 33
Crispo, F., Pietrafesa, M., Condelli, V., Maddalena, F., Bruno, G., Piscazzi, A., Sgambato, A., Esposito, F., & Landriscina, M. (2020) · Molecules · doi:10.3390/molecules25163754 · Cited by 32
Features of increased malignancy in eosinophilic clear cell renal cell carcinoma
Nilsson, H., Lindgren, D., Axelson, H., Brueffer, C., Saal, L. H., Lundgren, J., & Johansson, M. (2020) · The Journal of Pathology · doi:10.1002/path.5532 · Cited by 32
Ricci, L., Stanley, F. U., Eberhart, T., Mainini, F., Sumpton, D. P., & Cardaci, S. (2023) · Cell Death and Disease · doi:10.1038/s41419-023-05927-5 · Cited by 34
Metadata
- Authors
- Mullen, A. R., Wheaton, W. W., Jin, E. S., Chen, P.-H., Sullivan, L. B., Cheng, T., Yang, Y., Linehan, W. M., Chandel, N. S., & DeBerardinis, R. J.
- Affiliations
- The University of Texas Southwestern Medical Center (US)
- Northwestern University (US)
- National Institutes of Health (US)
- Harold C. Simmons Comprehensive Cancer Center (US)
- Corresponding author
- Chandel, Navdeep S.
- DeBerardinis, Ralph J.
- ORCID
- Venue
- Nature
- Published
- 2011-11-20
- Volume
- 481
- Issue
- 7381
- Pages
- 385-388
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- PMC
- PMC3262117
- OpenAlex
- W2092152920
- Cited by
- 1,328
- References
- 27
- Citations by year
- 2026: 81 · 2025: 92 · 2024: 63 · 2023: 70 · 2022: 107 · 2021: 107 · 2020: 91 · 2019: 88 · 2018: 82 · 2017: 84 · 2016: 96 · 2015: 98 · 2014: 99 · 2013: 86 · 2012: 80
- FWCI
- 29.04
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- Funders
- National Institutes of Health
- National Cancer Institute (R01CA123067, R01CA157996, T32CA009560)
- National Institute of General Medical Sciences (T32GM083831, T32GM008061)
- National Institute of Diabetes and Digestive and Kidney Diseases (K08DK072565, K01DK078933, DK078933)
- National Center for Research Resources (P41RR002584, RR‐02584)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Hypoxia, and Metabolism
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Lipids, and Metabolism
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolism, Diabetes, and Cancer
- Keywords
- reductive carboxylation, glutamine metabolism, IDH1, acetyl-CoA, lipogenesis, hypoxia, tumor growth, fumarate hydratase deficiency, renal carcinoma, TCA cycle
- MeSH terms
- Acetyl Coenzyme A, Animals, Carcinoma, Renal Cell, Electron Transport, Fumarate Hydratase, Glucose, Glutamine, Humans, Isocitrate Dehydrogenase, Kidney Neoplasms, Mitochondria, NADP, Neoplasms, Electron Transport Complex III, Cell Hypoxia, Citric Acid, Electron Transport Complex I, Cell Line, Tumor, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
